ASUS Republic of Gamers Announces ROG Strix GS-BE7200 Dual-Band WiFi 7 Gaming Router

ASUS Republic of Gamers Announces ROG Strix GS-BE7200 Dual-Band WiFi 7 Gaming Router

Features include boosted 5GHz range, ROG Gaming Network, and Smart Home Master controls KEY POINTS Dual-band WiFi 7 throughput of up to 7200Mbps with MLO and 4K-QAM Six internal antennas and boosted 5GHz range deliver up to 15% better throughput at...

Baidu Announces New Share Repurchase Program and Dividend Policy

Baidu Announces New Share Repurchase Program and Dividend Policy

BEIJING, Feb. 5, 2026 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced that its Board of Directors (the...

Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013

Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013

SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...

Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing

Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing

NEW YORK, TAIPEI, and TOKYO, Feb. 4, 2026 /PRNewswire/ -- Goldenstone Acquisition Limited (Ticker: GDST) ("Goldenstone"), a special purpose acquisition company listed in the U.S. capital market, recently announced the execution of a letter of intent...

CLPS Incorporation Announces Share Repurchase Program of Up to 1,000,000 Shares

CLPS Incorporation Announces Share Repurchase Program of Up to 1,000,000 Shares

HONG KONG, Feb. 4, 2026 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced that its Board of Directors has approved a share repurchase program. Under the program, the Company is authorized to repurchase up...

Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial

Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian...

Axcelis Announces Participation in SEMICON Korea 2026

Axcelis Announces Participation in SEMICON Korea 2026

Highlighting New Technologies That Advance Intelligent Semiconductor Manufacturing Solutions BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the...

ZTO Announces Proposed Offering of US$1.5 Billion Convertible Senior Notes

ZTO Announces Proposed Offering of US$1.5 Billion Convertible Senior Notes

SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Company"), today announced a proposed offering (the "Notes Offering") of US$1.5...

ZTO Announces Certain Preliminary Estimated Full Year 2025 Financial Results

ZTO Announces Certain Preliminary Estimated Full Year 2025 Financial Results

SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Company"), today announced certain preliminary estimated financial results for...

Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology...

  • 1
  • ...
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • ...
  • 79
  • menu
    menu